Condensed Statement of Stockholders' Equity - USD ($)	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Total
Beginning balance, shares at Dec. 31, 2017	22,803,533
Beginning balance, amount at Dec. 31, 2017	$ 2,280	$ 4,137,936	$ (1,067,901)	$ 3,072,315
Sale of common stock and warrants at $3.00 per share and placement agent warrants in private offering, net of issuance costs, shares	4,561,074
Sale of common stock and warrants at $3.00 per share and placement agent warrants in private offering, net of issuance costs, amount	$ 456	12,140,330		12,140,786
Share-based compensation expense		512,988		512,988
Net loss for the period			(3,336,435)	(3,336,435)
Ending balance, shares at Dec. 31, 2018	27,364,607
Ending balance, amount at Dec. 31, 2018	$ 2,736	16,791,254	(4,404,336)	12,389,654
Sale of common stock and warrants at $6.50 per share and placement agent warrants in public offering, net of issuance costs, shares	1,923,076
Sale of common stock and warrants at $6.50 per share and placement agent warrants in public offering, net of issuance costs, amount	$ 192	11,351,022		11,351,214
Common shares issued upon exercise of warrants at $3.00 per share, shares	127,649
Common shares issued upon exercise of warrants at $3.00 per share, amount	$ 13	382,934		382,947
Common shares issued upon exercise of warrants at $5.00 per share, net of issuance costs, shares	345,834
Common shares issued upon exercise of warrants at $5.00 per share, net of issuance costs, amount	$ 35	1,700,469		1,700,504
Common shares issued upon exercise of stock options, shares	38,750
Common shares issued upon exercise of stock options, amount	$ 4	58,121		58,125
Share-based compensation expense		1,536,096		1,536,096
Common shares issued for services, shares	30,000
Common shares issued for services, amount	$ 3	102,597		102,600
Net loss for the period			(8,325,488)	(8,325,488)
Ending balance, shares at Dec. 31, 2019	29,829,916
Ending balance, amount at Dec. 31, 2019	$ 2,983	$ 31,922,493	$ (12,729,824)	$ 19,195,652